Once again, the press release on the Myelos deal as well as the 8-K filing said that the 2.3 million shares the Myelos shareholders received are unregistered and locked up for two years. What is the connection you are making between that deal and the current weakness? How can they use these unregistered, locked-up shares to cover any short positions (at least for the next two years)?
Just curious if you see this stock escalating out of the 9-10 range. I have been in it for a while now (I am guessing 4 months) and have not not made a dime from it. All my other stocks are making me money.
I've held onto 3000 shrs of BTGC bought at $16.25 over 4 YEARS now and it's been DEAD MONEY. This has been during the biggest bull run of the century. So, if you're holding LT, get a clue - BTGC doesn't care about shareholders. They post very few news releases and when they do it's always about an imature drug clinical study phase nearing like that's some big news.
Sorry, faithful LT BTGC boardsters. I know I'll get a ration of sh-- back from you but telling it like it is - how it's been. My advice is to email the living daylights out BTGC IR while at the same time trading the stock until such day/year that this Co puts more money into PR and it's shareholders.